思创医惠(300078) - 2025 Q3 - 季度财报

Report Statement and Disclaimer This section outlines the company's commitment to the accuracy and completeness of its quarterly report and confirms the unaudited status of the financial statements - The Board of Directors, directors, and senior management guarantee the truthfulness, accuracy, and completeness of the quarterly report, free from false records, misleading statements, or major omissions, and assume individual and joint legal responsibility[3] - The company's principal, head of accounting, and head of accounting department declare and guarantee the truthfulness, accuracy, and completeness of the financial information in the quarterly report[3] - The financial report for this period is unaudited[4][26] Major Financial Data This section presents key financial data, including accounting figures, financial indicators, and non-recurring gains and losses, along with explanations for significant changes Major Accounting Data and Financial Indicators The company's Q3 operating revenue significantly decreased by 64.93% year-on-year, while net profit attributable to shareholders increased by 177.42%; year-to-date operating revenue grew by 6.95%, and net profit attributable to shareholders significantly increased by 98.32% but remained negative, with total assets and equity attributable to shareholders both declining Key Accounting Data and Financial Indicators (Current Reporting Period) | Item | Current Reporting Period (RMB) | Change from Prior Year (%) | | :--- | :--- | :--- | | Operating Revenue | 58,795,121.13 | -64.93% | | Net Profit Attributable to Shareholders of the Listed Company | 47,069,312.46 | 177.42% | | Net Profit Attributable to Shareholders of the Listed Company, Excluding Non-Recurring Gains and Losses | -95,132,022.26 | -51.46% | | Basic Earnings Per Share (RMB/share) | 0.05 | 183.33% | | Diluted Earnings Per Share (RMB/share) | 0.05 | 183.33% | | Weighted Average Return on Net Assets | -73.00% | -65.85% | Key Accounting Data and Financial Indicators (Year-to-Date) | Item | Year-to-Date (RMB) | Change from Prior Year (%) | | :--- | :--- | :--- | | Operating Revenue | 603,818,696.74 | 6.95% | | Net Profit Attributable to Shareholders of the Listed Company | -4,762,164.09 | 98.32% | | Net Profit Attributable to Shareholders of the Listed Company, Excluding Non-Recurring Gains and Losses | -157,687,268.14 | 45.03% | | Net Cash Flow from Operating Activities | 34,036,713.51 | 2,570.50% | | Basic Earnings Per Share (RMB/share) | 0.00 | 100.00% | | Diluted Earnings Per Share (RMB/share) | 0.00 | 100.00% | | Weighted Average Return on Net Assets | -82.28% | -25.76% | Key Accounting Data and Financial Indicators (End of Reporting Period) | Item | End of Current Reporting Period (RMB) | End of Prior Year (RMB) | Change from Prior Year (%) | | :--- | :--- | :--- | :--- | | Total Assets | 1,008,557,511.94 | 2,189,795,268.31 | -53.94% | | Total Equity Attributable to Shareholders of the Listed Company | 577,757,734.32 | 579,788,934.61 | -0.35% | Non-Recurring Gains and Losses Items and Amounts Total non-recurring gains and losses amounted to RMB 142,201,334.72 for the current period and RMB 152,925,104.05 year-to-date, primarily driven by gains from the disposal of non-current assets, including land, buildings, and equity of Yihui Technology Non-Recurring Gains and Losses Items and Amounts | Item | Amount for Current Period (RMB) | Amount Year-to-Date (RMB) | Notes | | :--- | :--- | :--- | :--- | | Gains and Losses from Disposal of Non-Current Assets | 141,896,892.28 | 149,983,086.27 | Includes sale of Yihui Technology's land, buildings, and equity | | Government Grants Recognized in Current Profit or Loss | 596,650.74 | 3,732,253.61 | | | Gains and Losses from Changes in Fair Value of Financial Assets and Liabilities Held by Non-Financial Enterprises, and Gains and Losses from Disposal of Financial Assets and Liabilities | 0 | -1,327,669.66 | | | Gains and Losses from Entrusted Investments or Asset Management | 0 | 1,422,599.28 | | | Other Non-Operating Income and Expenses | -267,089.52 | -858,861.01 | | | Less: Income Tax Impact | 25,118.99 | 25,677.28 | | | Impact on Minority Interests (After Tax) | -0.21 | 627.16 | | | Total | 142,201,334.72 | 152,925,104.05 | -- | - Gains and losses from disposal of non-current assets primarily resulted from the net proceeds of RMB 8,348,898.01 from the sale of Yihui Technology's land, buildings, and facilities in Binjiang District, and RMB 141,284,624.17 from the sale of Yihui Technology equity[6] Changes and Reasons for Major Accounting Data and Financial Indicators During the reporting period, multiple balance sheet, income statement, and cash flow statement items experienced significant changes, with asset and liability items largely decreasing due to the deconsolidation of Yihui Technology, while investment income and asset disposal gains substantially increased, and net cash flow from operating activities rose significantly due to reduced personnel costs - Multiple balance sheet items (e.g., notes receivable, accounts receivable, prepayments, inventories, contract assets, long-term receivables, investment properties, fixed assets, intangible assets) significantly decreased, primarily due to Yihui Technology no longer being consolidated[9] - Multiple liability items (e.g., accounts payable, contract liabilities, employee compensation payable, taxes payable, other payables, non-current liabilities due within one year, other current liabilities) significantly decreased, primarily due to Yihui Technology no longer being consolidated, with some items also involving repayment of borrowed funds[9][10] - Long-term payables increased by 51.05%, primarily due to the receipt of asset disposal proceeds[10] - Taxes and surcharges decreased by 75.41% year-on-year, primarily due to taxes paid on property disposal in the prior period[10] - Selling expenses, R&D expenses, and financial expenses decreased by 35.39%, 51.29%, and 50.26% respectively, primarily due to reduced operating scale, decreased R&D investment in the medical sector, and accrued convertible bond interest in the prior year[10] - Investment income significantly increased by 11,881.02% year-on-year, primarily due to gains from the disposal of subsidiary Yihui Technology in the current period[10] - Net cash flow from operating activities increased by 2,570.50% year-on-year, primarily due to reduced personnel costs[10] Shareholder Information This section details the company's shareholder structure, including the total number of common shareholders, top ten shareholders' holdings, and changes in restricted shares Total Number of Common Shareholders and Top Ten Shareholders' Shareholdings As of the end of the reporting period, Cangnan Sijia IoT Smart Partnership (Limited Partnership), Lu Nan, and Yunhailian Holdings Co., Ltd. were the top three shareholders, holding 5.72%, 5.61%, and 5.44% respectively, with all shares of Yunhailian Holdings Co., Ltd. pledged, and some shares of Zhang Lizhong pledged and frozen - As of the end of the reporting period, the total number of common shareholders was 58,359[12] Top 10 Shareholders' Shareholdings | Shareholder Name | Shareholder Type | Shareholding Percentage | Number of Shares Held (shares) | Pledged, Marked, or Frozen Status | | :--- | :--- | :--- | :--- | :--- | | Cangnan Sijia IoT Smart Partnership (Limited Partnership) | Domestic Non-State-Owned Legal Person | 5.72% | 63,890,185 | N/A | | Lu Nan | Domestic Natural Person | 5.61% | 62,739,500 | N/A | | Yunhailian Holdings Co., Ltd. | Domestic Non-State-Owned Legal Person | 5.44% | 60,858,803 | Pledged 60,858,803 | | Fang Zhenchun | Domestic Natural Person | 2.11% | 23,546,600 | N/A | | Zhang Lizhong | Domestic Natural Person | 1.65% | 18,450,902 | Pledged 14,415,027, Frozen 18,450,902 | | Cangnan Xinchuang Enterprise Management Partnership (Limited Partnership) | Domestic Non-State-Owned Legal Person | 0.56% | 6,266,866 | N/A | | Hangzhou Botai Investment Management Co., Ltd. | Domestic Non-State-Owned Legal Person | 0.54% | 6,006,776 | N/A | | Liao Yannan | Domestic Natural Person | 0.45% | 5,000,000 | N/A | | Duan Liping | Domestic Natural Person | 0.45% | 5,000,000 | N/A | | Hongtu Innovation Fund - Jiaxing Jingmei Zhonghe Investment Partnership (Limited Partnership) - Hongtu Innovation Hongren No. 86 Single Asset Management Plan | Other | 0.40% | 4,484,304 | N/A | - Mr. Lu Nan, a natural person shareholder of the company, holds 59.02% equity in Hangzhou Botai Investment Management Co., Ltd., a legal person shareholder[12] - Shareholder Duan Liping holds 5,000,000 shares through a margin trading and securities lending account, and Xia Zongshui holds 3,617,100 shares through a margin trading and securities lending account[13] Total Number of Preferred Shareholders and Top Ten Preferred Shareholders' Shareholdings The company has no preferred shareholders - The company has no preferred shareholders[13] Changes in Restricted Shares During the reporting period, executive restricted shares held by Zhang Lizhong, Peng Jun, and Hu Kaiyan were released on February 17, 2025, while Hangzhou Botai Investment Management Co., Ltd. still holds 4,505,082 IPO restricted shares, with 25% of its company shares unlocked annually Changes in Restricted Shares | Shareholder Name | Restricted Shares at Beginning of Period (shares) | Restricted Shares Released in Current Period (shares) | Restricted Shares Increased in Current Period (shares) | Restricted Shares at End of Period (shares) | Reason for Restriction | Proposed Release Date | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Zhang Lizhong | 13,838,176 | 13,838,176 | 0 | 0 | Executive Restricted Shares | Released on February 17, 2025 | | Peng Jun | 3,750 | 3,750 | 0 | 0 | Executive Restricted Shares | Released on February 17, 2025 | | Hu Kaiyan | 1,500 | 1,500 | 0 | 0 | Executive Restricted Shares | Released on February 17, 2025 | | Hangzhou Botai Investment Management Co., Ltd. | 4,505,082 | 0 | 0 | 4,505,082 | IPO Restricted Shares | 25% of its shares in the company are unlocked annually | | Total | 18,348,508 | 13,843,426 | 0 | 4,505,082 | -- | -- | Other Important Matters This section covers significant corporate events, including the completion of a major asset sale, termination of fundraising projects, and progress on the proposed change of controlling shareholder Completion of Major Asset Sale and Related Party Transaction The company completed the sale of 100% equity in Yihui Technology to Cangnan Shanhai Digital Technology Co., Ltd. on August 5, 2025, with the target assets transferred and registered, and industrial and commercial change procedures finalized - The company completed the sale of 100% equity in Yihui Technology to Cangnan Shanhai Digital Technology Co., Ltd. on August 5, 2025[15] - The target assets have been transferred and registered under Shanhai Digital, and Yihui Technology has completed the industrial and commercial change registration procedures[15] Termination of Fundraising Projects and Replenishment of Working Capital The company terminated three fundraising projects, including the "IoT Smart Healthcare Traceability Management Project" and "Medical Big Data Application R&D Center" from its 2018 non-public offering, and the "Internet + AI Medical Innovation Operation Service Project" from its 2020 convertible bond project, with all remaining funds used to permanently replenish working capital and all special accounts closed - The company terminated the "IoT Smart Healthcare Traceability Management Project" and "Medical Big Data Application R&D Center" from its 2018 non-public offering of shares project[16] - The company terminated the "Internet + AI Medical Innovation Operation Service Project", "Marketing System Expansion Project", and "New Generation Smart Healthcare Application R&D Project Based on AI and Microservice Cloud Architecture" from its 2020 convertible bond project[16] - All remaining raised funds were transferred to the company's own capital account on August 15, 2025, and all special accounts for raised funds have been closed[16] Progress on Proposed Change of Controlling Shareholder and Actual Controller Mr. Lu Nan, the company's largest shareholder, signed a share transfer agreement with Cangnan County Industrial Construction Investment Co., Ltd. on April 26, 2025, to transfer 5.61% of his shares, with a supplemental agreement signed on September 1, 2025, which is expected to change the company's controlling shareholder and actual controller - Mr. Lu Nan, the company's largest shareholder, intends to transfer 62,739,500 shares (representing 5.61% of the total share capital) to Cangnan County Industrial Construction Investment Co., Ltd. via agreement transfer[17] - Mr. Lu Nan and Cangnan Jiantou signed a "Supplemental Agreement to the Share Transfer Agreement" on September 1, 2025[17] - This share transfer is expected to result in a change of the company's controlling shareholder and actual controller[17] Quarterly Financial Statements This section presents the company's unaudited quarterly financial statements, including the consolidated balance sheet, income statement, and cash flow statement, along with notes on the first-time adoption of new accounting standards Financial Statements This section includes the company's consolidated balance sheet as of September 30, 2025, and the consolidated income statement and cash flow statement for the period from the beginning of 2025 to the end of the reporting period, reflecting the company's assets, liabilities, equity, income, expenses, and cash flows during the reporting period Consolidated Balance Sheet This table provides a detailed overview of the company's financial position, presenting assets, liabilities, and equity as of September 30, 2025 Key Data from Consolidated Balance Sheet (September 30, 2025) | Item | Balance at Period End (RMB) | Balance at Period Beginning (RMB) | | :--- | :--- | :--- | | Cash and Cash Equivalents | 492,649,508.87 | 415,200,644.88 | | Financial Assets Held for Trading | 53,602,850.48 | 205,704,709.66 | | Accounts Receivable | 82,076,433.03 | 395,319,679.02 | | Inventories | 59,361,030.18 | 176,396,663.36 | | Total Current Assets | 703,188,705.15 | 1,290,839,328.94 | | Long-Term Equity Investments | 72,252,216.49 | 104,540,469.97 | | Investment Properties | 13,998,884.70 | 292,351,288.60 | | Fixed Assets | 99,685,323.27 | 346,767,620.14 | | Total Non-Current Assets | 305,368,806.79 | 898,955,939.37 | | Total Assets | 1,008,557,511.94 | 2,189,795,268.31 | | Accounts Payable | 40,449,311.42 | 319,186,637.94 | | Contract Liabilities | 9,033,144.98 | 56,886,458.05 | | Other Payables | 73,411,309.26 | 631,253,933.93 | | Total Current Liabilities | 143,815,057.28 | 1,402,583,357.34 | | Long-Term Payables | 232,211,857.80 | 153,736,323.48 | | Total Liabilities | 417,703,743.44 | 1,600,932,000.91 | | Total Equity Attributable to Parent Company Shareholders | 577,757,734.32 | 579,788,934.61 | | Total Equity | 590,853,768.50 | 588,863,267.40 | | Total Liabilities and Equity | 1,008,557,511.94 | 2,189,795,268.31 | Consolidated Income Statement from Year Beginning to End of Reporting Period This table summarizes the company's financial performance, detailing revenues, costs, and profits for the period from January to September 2025 Key Data from Consolidated Income Statement (January-September 2025) | Item | Amount for Current Period (RMB) | Amount for Prior Period (RMB) | | :--- | :--- | :--- | | Total Operating Revenue | 603,818,696.74 | 564,563,042.63 | | Total Operating Costs | 711,900,612.78 | 747,741,398.44 | | Selling Expenses | 33,787,538.12 | 52,290,919.15 | | Administrative Expenses | 72,585,253.61 | 82,581,715.07 | | Research and Development Expenses | 42,152,641.88 | 86,530,617.16 | | Financial Expenses | 19,899,543.47 | 40,006,082.67 | | Other Income | 7,417,902.30 | -880,360.81 | | Investment Income | 144,803,779.80 | -1,229,128.03 | | Operating Profit | -3,050,240.86 | -283,283,593.21 | | Total Profit | -3,909,101.87 | -282,852,044.95 | | Net Profit | -6,485,797.26 | -285,718,834.44 | | Net Profit Attributable to Parent Company Shareholders | -4,762,164.09 | -283,640,006.17 | | Basic Earnings Per Share | 0.00 | -0.31 | | Diluted Earnings Per Share | 0.00 | -0.31 | Consolidated Cash Flow Statement from Year Beginning to End of Reporting Period This table presents the company's cash inflows and outflows from operating, investing, and financing activities for the period from January to September 2025 Key Data from Consolidated Cash Flow Statement (January-September 2025) | Item | Amount for Current Period (RMB) | Amount for Prior Period (RMB) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 34,036,713.51 | 1,274,545.97 | | Net Cash Flow from Investing Activities | 482,422,914.64 | 470,688,133.32 | | Net Cash Flow from Financing Activities | -336,463,972.37 | -476,415,935.60 | | Net Increase in Cash and Cash Equivalents | 181,136,253.08 | -1,697,391.05 | | Cash and Cash Equivalents at Period End | 492,649,508.87 | 351,567,537.33 | - Net cash flow from operating activities significantly increased by 2,570.50%, primarily due to reduced personnel costs[10][24] - Within cash inflows from investing activities, net cash received from disposal of subsidiaries and other business units was RMB 230,196,018.20[24] - Within cash inflows from financing activities, other cash received related to financing activities was RMB 630,000,000.00[25] First-Time Adoption of New Accounting Standards The company adopted new accounting standards for the first time in 2025 but did not adjust relevant items in the financial statements at the beginning of the first adoption year - The company adopted new accounting standards for the first time in 2025 but did not adjust relevant items in the financial statements at the beginning of the first adoption year[26] Audit Report The company's Q3 financial report is unaudited - The company's Q3 financial report is unaudited[26]